Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Consensus Recommendation of “Hold” from Analysts

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) has been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company.

A number of research firms recently commented on CZMWY. Sanford C. Bernstein cut Carl Zeiss Meditec to a “market perform” rating in a report on Monday. The Goldman Sachs Group lowered Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 20th.

Carl Zeiss Meditec Stock Up 4.0%

Shares of CZMWY stock opened at $34.38 on Monday. The firm’s 50-day moving average is $46.80 and its two-hundred day moving average is $50.37. Carl Zeiss Meditec has a 12 month low of $32.59 and a 12 month high of $76.28.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.